Global economic and health benefits of tobacco control: Part 2

Clinical Pharmacology and Therapeutics

Volumn 86, Issue 3, 2009, Pages 272-280

  Wipfli, H ^a,b   Samet, J M ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIR CONDITIONING; AMBIENT AIR; DISEASE SURVEILLANCE; ECONOMIC ASPECT; EPIDEMIC; FINANCIAL MANAGEMENT; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH CARE POLICY; HISTORY; HUMAN; LAW; LAW SUIT; MASS MEDIUM; MEDICAID; MORTALITY; PANDEMIC; PASSIVE SMOKING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK REDUCTION; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO INDUSTRY; WORLD HEALTH ORGANIZATION;

HARM REDUCTION; HEALTH; HISTORY, 20TH CENTURY; HUMANS; LEGISLATION, MEDICAL; SMOKING CESSATION; TOBACCO USE DISORDER; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 69549103069     PISSN: 00099236     EISSN: 15326535     Source Type: Journal    
DOI: 10.1038/clpt.2009.94     Document Type: Review

References (49)

1. Royal College of Physicians of London. Smoking and Health. Summary of a Report of the Royal College of Physicians of London on Smoking in Relation to Cancer of the Lung and Other Diseases S2-S70 (Pitman Medical Publishing, London, 1962).
2. US Department of Health Education and Welfare. Smoking and Health. Report of the Advisory Committee to the Surgeon General. DHEW Publication No. [PHS] 1103 (US Government Printing Office, Washington, DC, 1964).
3. Oettle, A.G. Cigarette smoking as the major cause of lung cancer. III. S. Afr. Med. J. 37, 983-987 (1963).
4. US Department of Justice. Litigation against tobacco companies 〈http://www.usdoj.gov/civil/cases/tobacco2/index.htm〉. Accessed 18 February 2009.
5. Brandt, A.M. The Cigarette Century: The Rise, Fall, and Deadly Persistence of the Product That Defined America (Basic Books, New York, 2007).
6. Barnoya, J. & Glantz, S.A. The tobacco industry's worldwide ETS consultants project: European and Asian components. Eur. J. Public Health 16, 69-77 (2005). (Pubitemid 43214355)
7. Pan American Health Organization. Profits over people. Tobacco industry activities to market cigarettes and undermine public health in Latin America and the Caribbean (Washington, DC, 2002).
8. Drope, J. & Chapman, S. Tobacco industry efforts at discrediting scientific knowledge of environmental tobacco smoke: a review of internal industry documents. J. Epidemiol. Community Health 55, 588-594 (2001). (Pubitemid 32662062)
9. Fichtenberg, C.M. & Glantz, S.A. Effect of smoke-free workplaces on smoking behaviour: systematic review. BMJ 325, 188-194 (2002).
10. Samet, J.M. et al. (2005). ASHRAE position document on environmental tobacco smoke (American Society of Heating, Refrigeration and Air-Conditioning Engineers, Atlanta, GA, 2005).
11. American Nonsmokers' Rights Foundation. Summary of 100% smokefree state laws and population protected by 100% U.S. smokefree laws 〈http://www.no- smoke.org/pdf/SummaryUSPopList.pdf〉 (2006). Accessed 18 February 2009.
12. Global Smokefree Partnership. 〈http://www.globalsmokefree.com/gsp/ 〉 (2008). Accessed 18 February 2009.
13. National Cancer Institute. The role of the media in promoting and reducing tobacco use. Tobacco control monograph no.19 (US Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Bethesda, MD, 2008).
14. Miura, M., Daynard, R.A. & Samet, J.M. The role of litigation in tobacco control. Salud Publica Mex. 48, S121-S136 (2006).
15. Cipollone v. Liggett Group (Supreme Court, 1992).
16. Legacy Tobacco Documents Library. 〈http://legacy.library.ucsf.edu/ 〉 (2002). Accessed 18 February 2009.
17. Schroeder, S.A. Tobacco control in the wake of the 1998 master settlement agreement. N. Engl. J. Med. 350, 293-301 (2004).
18. Gostin, L.O. The "tobacco wars" - global litigation strategies. JAMA 298, 2537-2539 (2007).
19. Daynard, R.A., Bates, C. & Francey, N. Tobacco litigation worldwide. BMJ 320, 111-113 (2000).
20. Tobacco Control Policy: Strategies, Successes, and Setbacks (eds. De Beyer, J. & Brigden, L.W.) (The World Bank and Research for International Tobacco Control, Washington, DC, 2003).
21. Frankel, G. Thailand resists U.S. brand assault. Washington Post A14-A15 (1996).
22. Frankel, G. U.S. aided cigarette firms in conquests across Asia. Washington Post A24 (1996).
23. Rupert, J. & Frankel, G. In ex-Soviet markets, U.S. brands took on role of capitalist liberator. Washington Post A18 (1998).
24. World Health Organization. World Health Assembly Resolution WHA 52.18 (World Health Organization, Geneva, Switzerland, 1999).
25. WHO Framework Convention on Tobacco Control 〈http://www.who.int/ fctc/en/〉 (2003). Updated 17 February 2006.
26. World Health Organization.WHO report on the global tobacco epidemic, 2008: the MPOWER package (World Health Organization, Geneva, Switzerland, 2008).
27. World Health Organization. GATS (Global Adult Tobacco Survey) 〈http://www.who.int/tobacco/surveillance/gats/en/index.html〉 (2007). Accessed 10 February 2009.
28. Hatsukami, D. & Zeller, M. Tobacco harm reduction: the need for research to inform policy. Psychological Science Agenda 18, 5-8 (2004).
29. Warner, K.E. Tobacco harm reduction: promise and perils. Nicotine Tob. Res. 4 (suppl. 2), S61-S71 (2002).
30. Stratton, K., Shetty, P., Wallace, R. & Bondurant, S. (eds.). Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction (National Academy Press, Washington, DC, 2001).
31. National Cancer Institute. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and tobacco control monograph 13 (US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Bethesda, MD, 2001).
32. International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC monograph 83 (International Agency for Research on Cancer, Lyon, France, 2004).
33. US Department of Health and Human Services. The health consequences of smoking. A report of the Surgeon General (US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA, 2004).
34. Roosaar, A., Johansson, A.L., Sandborgh-Englund, G., Axéll, T. & Nyrén, O. Cancer and mortality among users and nonusers of snus. Int. J. Cancer 123, 168-173 (2008).
35. Lundqvist, G., Sandström, H., Ohman, A. & Weinehall, L. Patterns of tobacco use: a 10-year follow-up study of smoking and snus habits in a middle-aged Swedish population. Scand. J. Public Health 37, 161-167 (2008).
36. Avila-Tang, E., Apelberg, B.J., Yamaguchi, N., Katanoda, K., Sobue, T. & Samet, J.M. Modelling the health benefits of smoking cessation in Japan. Tob. Control 18, 10-17 (2009).
37. Apelberg, B.J. & Samet, J.M. Estimating the impact of tobacco control policies on future mortality patterns in the U.S. In Social and Economic Consequences of Tobacco Control Policy (eds. Bearman, P., Neckerman, K. & Wright, L.) (Columbia University Press, New York, 2009).
38. Messer, K., Trinidad, D.R., Al-Delaimy, W.K. & Pierce, J.P. Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am. J. Public Health 98, 317-322 (2008). (Pubitemid 351317567)
39. Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses - United States, 2000-2004. MMWR Morb. Mortal. Wkly. Rep. 57, 1226-1228 (2008).
40. Global Youth Tobacco Survey Collaborative Group. Tobacco use among youth: a cross country comparison. Tob. Control 11, 252-270 (2002).
41. Fritschler, A.L. Smoking and Politics: Policymaking and the Federal Bureaucracy (Prentice Hall, Englewood Cliffs, NJ, 1969).
42. FDA v. Brown & Williamson Tobacco Corp. (Supreme Court, 2000).
43. Saloojee, Y. & Dagli, E. Tobacco industry tactics for resisting public policy on health. Bull. World Health Organ. 78, 902-910 (2000). (Pubitemid 30629261)
44. White, C. & Hammond, R. Voice of truth: Vol 1. Multinational tobacco industry activity in the Middle East: a review of internal industry documents (World Health Organization & Regional Office of the Eastern Mediterranean, Cairo, 2007).
45. Zeltner, T., Kessler, D., Martiny, A. & Randera, F. Tobacco industry strategies to undermine tobacco control activities at the World Health Organization (World Health Organization, Geneva, Switzerland, 2000).
46. WHO. Elaboration of guidelines for implementation of the Convention (decision FCTC/COP1(15)). Conference of the parties to the WHO Framework Convention on Tobacco Control, second session, Bangkok, Thailand, 26 April 2007.
47. World Health Organization & Tobacco Free Initiative. WHO Study Group on Tobacco Product Regulation (TobReg). 〈http://www.who.int/tobacco/global- interaction/tobreg/en/〉. Accessed 18 February 2009.
48. Samet, J.M., Yach, D., Taylor, C. & Becker, K. Research for effective global tobacco control in the 21st century: report of a working group convened during the 10th World Conference on Tobacco or Health. Tob. Control 7, 72-77 (1998).
49. US Department of Health and Human Services. Reducing tobacco use: a report of the Surgeon General. Report no. S/N 017-001-00544-4 (US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA, 2000).